AI assistant
Altimmune, Inc. — Director's Dealing 2024
Aug 21, 2024
33207_dirs_2024-08-20_8b69d17d-27de-4627-b03f-4bcb5f00e79d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Altimmune, Inc. (ALT)
CIK: 0001326190
Period of Report: 2024-08-19
Reporting Person: Drutz David (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-19 | Common Stock, par value $0.0001 | M | 20000 | $2.60 | Acquired | 49785 | Indirect |
| 2024-08-19 | Common Stock, par value $0.0001 | S | 7827 | $6.93 | Disposed | 41958 | Indirect |
| 2024-08-19 | Common Stock, par value $0.0001 | M | 21750 | $2.50 | Acquired | 63708 | Indirect |
| 2024-08-19 | Common Stock, par value $0.0001 | S | 8184 | $6.88 | Disposed | 55524 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-08-19 | Stock Options (option to buy) | $2.60 | M | 20000 | Disposed | 2029-01-02 | Common Stock, par value $0.0001 (20000) | Direct |
| 2024-08-19 | Stock Options (option to buy) | $2.50 | M | 21750 | Disposed | 2033-09-28 | Common Stock, par value $0.0001 (21750) | Direct |
Footnotes
F1: Shares received upon exercise were immediately transferred to Pacific Biopharma Associates, LLC.
F2: Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President.
F3: This sale represents shares sold to cover the exercise price.
F4: The shares underlying the option became vested and exercisable in two equal installments on February 28, 2019 and August 30, 2019, in each case, generally subject to the reporting person's continued service through the applicable vesting date.
F5: The shares underlying the option became vested and exercisable in substantially equal monthly installments over the 12 months following September 28, 2023, subject to the reporting person's continued service through the applicable vesting date.